January 4, 2016

Online registration is now closed. Please register on site at the meeting.
Access the agenda and other meeting information on the NRG Oncology website.

Please note that the HOTEL registration deadline has been extended through tomorrow, January 5, 2016.

RTOG 1216: Amendment 5, Version Date: November 9, 2015. This amendment will be available on the Group and CTSU websites on January 5, 2016.

RTOG 1216: The Blank Rave form has been revised and is available on the RTOG legacy website. Use the revised version date: November 11, 2015, effective January 5, 2016.

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001 and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for February 17, 2016.

VisionTree Workshop at NRG Oncology Semiannual Meeting: Thursday, January 21, 2016. This will be an in person workshop. Please see the agenda on the NRG website.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

The NRG Oncology is polling network contact PIs and Lead RAs to assess interest in a study to determine the clinically appropriate time interval (5 vs. 10 years) for follow-up of patients with 1-2 non-advanced adenomatous colon polyps. The survey responses are due by Friday, January 8, 2016. Click here for a copy of the original survey request.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Bazan JG, White JR. The Role of Postmastectomy Radiation Therapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy. Semin Radiat Oncol. 2016 Jan;26(1):51-8. doi: 10.1016/j.semradonc.2015.08.001. Epub 2015 Aug 29. Review. PubMed PMID: 26617210. Read more

Mitin T, George A, Zietman AL, Heney NM, Kaufman DS, Uzzo RG, Dreicer R, Wallace HJ 3rd, Souhami L, Dobelbower MC, Sandler HM, Shipley WU. Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):67-74. doi: 10.1016/j.ijrobp.2015.09.030. Epub 2015 Sep 28. PubMed PMID: 26700703; PubMed Central PMCID: PMC4690848. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming abstract submission deadlines

American Brachytherapy Society (ABS), June 27-29, 2016, San Francisco, CA; abstract submission due to publications committee Dec 28, 2015; meeting abstract submission deadline Jan 8, 2016.

American College of Radiology (ACR), May 15-19, 2016, Washington DC; abstract submission due to publications committee Dec 28, 2015; meeting abstract submission deadline Jan 8, 2016.

American Head & Neck Society (AHNS), Jul 16-20, 2016, Seattle, WA; abstract submission due to publications committee Dec 28, 2015; meeting abstract submission deadline Jan 8, 2016.

American Society of Clinical Oncology (ASCO), Jun 3-7, 2016, Chicago, IL; due to publications committee January 12, 2016; meeting abstract submission deadline Feb 2, 2016.

American Society for Radiation Oncology (ASTRO), Sep 25-28, 2016, Boston, MA; due to publications committee Feb 3, 2016; meeting abstract submission deadline Feb 17, 2016

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103